-
Mashup Score: 6
Neurology Today Editor-in-Chief Joseph E. Safdieh,MD, FAAN, highlights new research that casts doubt on the future of BTK inhibitors for MS, an assessment of the cost-effectiveness of lecanemab, and findings that COVID vaccines are not significantly associated with adverse neurologic events.
Source: traffic.libsyn.comCategories: General Medicine News, NeurologyTweet
-
Mashup Score: 7SARS-CoV-2 and dopamine neurons, valproate risks for men, neurologists on locum tenens - 8 month(s) ago
Neurology Today Editor-in-Chief Joseph E. Safdieh, MD, FAAN, highlights new stories reporting on the impact of SARS-CoV2 on dopamine neurons, a European Medicines Agency warning about valproate risks for men, and neurologists on the pros and cons of working locum tenens.
Source: traffic.libsyn.comCategories: General Medicine News, NeurologyTweet
-
Mashup Score: 3Special Edition: A Focus on Obesity. Part 2: Navigating Lifestyle Modifications and Treatment Innovations - 8 month(s) ago
In this highly informative episode of Diabetes Day by Day, hosts Dr. Neil Skolnik and Dr. Sara Wettergreen explore the latest in obesity management and treatment with a dual focus: lifestyle modifications and new medications. Recognizing obesity as a critical factor in overall health, Drs. Skolnik and Wettergreen are joined by Drs. Susan Fiddler and Wesley Nuffer to discuss the multifaceted approaches to obesity management. This is the second of a three-part series of Diabetes Day by Day that focuses on the critical issue of obesity, offering professional insights and advice to sustain weight management. Learn about lifestyle strategies for treating obesity, including eating habits, physical activity, and behavioral approaches, as well as groundbreaking medications offering new hope for those struggling with obesity. The Focus on Obesity series is a collaborative project of the American Diabetes Association and the American Academy of Family Physicians. The entire program will comprise
Source: traffic.libsyn.comCategories: General Medicine News, EndocrinologyTweet-
Tune in to our latest special edition episode of #DiabetesDayByDay, A Focus on Obesity. Part 2: Navigating Lifestyle Modifications and Treatment Innovations, which is a collaborative effort between the ADA and @aafp. Listen now at https://t.co/5n4wiDCxHF. 🎧@LillyPad @novonordisk https://t.co/D19xybDdMl
-
-
Mashup Score: 1AI and 911 stroke detection, iatrogenic Alzheimer’s and human growth hormone, seizure dogs and refractory epilepsy - 9 month(s) ago
Neurology Today Editor-in-Chief Joseph E. Safdieh, MD, FAAN, highlights new stories reporting on the use of AI in EMS systems for stroke detection, the association between human growth hormone and iatrogenic Alzheimer’s, and seizure dogs for refractory epilepsy.
Source: traffic.libsyn.comCategories: General Medicine News, NeurologyTweet
-
Mashup Score: 5Special Edition: A Focus on Obesity. Part 1: A Shift in Perspective - 9 month(s) ago
In this enlightening episode of Diabetes Day by Day, hosts Dr. Neil Skolnik and Dr. Sara Wettergreen engage in a profound discussion on the topic of obesity, a pressing health issue that has seen a dramatic increase over the past 50 years. They are joined by Dr. Margarita McDonald, an obesity medical specialist, along with her patient, Tamika Holland, who shares her personal journey with obesity. This episode sheds light on the critical issue of obesity, offering both professional insights and personal experiences to foster a deeper understanding of the disease. By exploring the medical, psychological, and environmental aspects of obesity, Neil, Sara, Margarita, and Tamika provide a comprehensive overview that aims to inform, inspire, and encourage positive change in the way we view and care for obesity. The Focus on Obesity series is a collaborative project of the American Diabetes Association and the American Academy of Family Physicians. The entire program will comprise a total of s
Source: traffic.libsyn.comCategories: General Medicine News, EndocrinologyTweet
-
Mashup Score: 6Biomarker for migraine; posterior cortical atrophy gene therapy for neuromuscular disorders - 9 month(s) ago
Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses a new study showing retinal vascular perfusion as a migraine biomarker, clinical and pathophysiological correlates of posterior cortical atrophy, and advances in gene therapies for neuromuscular disorders.
Source: traffic.libsyn.comCategories: General Medicine News, NeurologyTweet
-
Mashup Score: 1Cerebral amyloid angiopathy and nontraumatic subdural hemorrhage, AI for neurology boards, weight loss drugs and neurologic conditions - 10 month(s) ago
Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses new studies showing the cerebral amyloid angiopathy as a risk factor for nontraumatic subdural hemorrhage, AI beats humans in neurology-like boards, and the impact of popular weight loss drugs on neurologic conditions.
Source: traffic.libsyn.comCategories: General Medicine News, NeurologyTweet
-
Mashup Score: 3Rising incidence of Creutzfeldt-Jakob disease, therapy for prodromal migraine, neurotrauma of blast injury - 10 month(s) ago
Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses new studies showing the rising incidence of Creutzfeldt-Jakob disease, an effective therapy for prodromal migaine, and neuroinflammation in military personnel exposed to blast injury.
Source: traffic.libsyn.comCategories: General Medicine News, NeurologyTweet-
Tune into the #NeurologyToday in 5 #podcast to Editor in Chief @BrainHealthMD, share more about our upcoming issue, featuring stories about the rising incidence of #CreutzfeldtJakobDisease, prodromal #migraine therapy, and much more: https://t.co/lbMz6iEEjr #NeuroTwitter #CJD https://t.co/l6vTKRWU8P
-
-
Mashup Score: 4New Year, New Goals - 10 month(s) ago
Join Drs. Skolnik and Wettergreen, along with special guests: Sean Oser, MD, MPH – Director of the Innovation Program at the University of Colorado School of Medicine, Associate Director of the Primary Care Diabetes Lab, and an Associate Professor in the Department of Family Medicine, and William Polonsky, PhD, CDCES – President and Co-founder of the Behavioral Diabetes Institute. Together, they will delve into the topics of goal setting and planning for the upcoming year while managing diabetes. Discover how you can approach these aspects with a mindset of self-compassion and appreciation for your unique self. Share your diabetes story with us by leaving a message at (703) 755-7288. You might be featured on a future Diabetes Day by Day episode.
Source: traffic.libsyn.comCategories: General Medicine News, EndocrinologyTweet-
🎉 New Year, New Goals! 🎉 - Our latest episode of #DiabetesDayByDay is finally here! In this episode, we had two guests who shared their brilliant insights & tips on goal setting & planning for the upcoming year, all while managing diabetes. Listen NOW: https://t.co/90Ld0hnd7o! https://t.co/lt0qL3qxE2
-
-
Mashup Score: 3DBS and cognition in severe TBI, in utero exposure to antiseizure drugs, best advances of 2023 - 11 month(s) ago
Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses new studies on the impact of deep brain stimulation on cognition in severe traumatic brain injury and how adaptive functioning is impacted in children exposed to antiseizure drugs in utero, and the editorial board’s picks for the best advances of 2023.
Source: traffic.libsyn.comCategories: General Medicine News, NeurologyTweet
Want to know what’s coming up in our new issue, out Thursday? Listen to the latest episode of the #NeurologyToday in 5 #podcast, hosted by our editor in chief, @BrainHealthMD: https://t.co/GX3o09gU8i #NeuroTwitter @AANMember https://t.co/GwYYmZoCWY